Dystonia Linked to EIF4A2 Haploinsufficiency: A Disorder of Protein Translation Dysfunction
Movement Disorders · 2023
DOI: 10.1002/mds.29562 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, 2023. Verfasst von Philip Harrer und 27 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany. Hauptthemen laut MEDLINE: Dystonia, Dystonic Disorders, MicroRNAs, Movement Disorders. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Background
Protein synthesis is a tightly controlled process, involving a host of translation‐initiation factors and microRNA‐associated repressors. Variants in the translational regulator EIF2AK2 were first linked to neurodevelopmental‐delay phenotypes, followed by their implication in dystonia. Recently, de novo variants in EIF4A2 , encoding eukaryotic translation initiation factor 4A isoform 2 (eIF4A2), have been described in pediatric cases with developmental delay and intellectual disability.
Objective
We sought to characterize the role of EIF4A2 variants in dystonic conditions.
Methods
We undertook an unbiased search for likely deleterious variants in mutation‐constrained genes among 1100 families studied with dystonia. Independent cohorts were screened for EIF4A2 variants. Western blotting and immunocytochemical studies were performed in patient‐derived fibroblasts.
Results
We report the discovery of a novel heterozygous EIF4A2 frameshift deletion (c.896_897del) in seven patients from two unrelated families. The disease was characterized by adolescence‐ to adulthood‐onset dystonia with tremor. In patient‐derived fibroblasts, eIF4A2 production amounted to only 50% of the normal quantity. Reduction of eIF4A2 was associated with abnormally increased levels of IMP1, a target of Ccr4‐Not, the complex that interacts with eIF4A2 to mediate microRNA‐dependent translational repression. By complementing the analyses with fibroblasts bearing EIF4A2 biallelic mutations, we established a correlation between IMP1 expression alterations and eIF4A2 functional dosage. Moreover, eIF4A2 and Ccr4‐Not displayed significantly diminished colocalization in dystonia patient cells. Review of international databases identified EIF4A2 deletion variants (c.470_472del, c.1144_1145del) in another two dystonia‐affected pedigrees.
Conclusions
Our findings demonstrate that EIF4A2 haploinsufficiency underlies a previously unrecognized dominant dystonia‐tremor syndrome. The data imply that translational deregulation is more broadly linked to both early neurodevelopmental phenotypes and later‐onset dystonic conditions. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Neurogenomics, Helmholtz Zentrum München, Munich, Germany.
- Institute of Human Genetics, School of Medicine, Technical University of Munich, Munich, Germany.
- Department of Neurology, P.J. Safarik University, Kosice, Slovak Republic.
- Department of Neurology, University Hospital of L. Pasteur, Kosice, Slovak Republic.
- Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
- Institute of Neurogenetics, University of Lübeck, Lübeck, Germany.
ORCID-Profile: Matej Škorvánek, Friederike Borngräber, Miriam Ostrozovicova, Kishore R Kumar, Niccolo E Mencacci, Manju A Kurian, Alessio Di Fonzo, Katja Lohmann, Bernhard Haslinger, Robert Jech, Michael Zech
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Harrer, P., Škorvánek, M., Kittke, V., Dzinovic, I., Borngräber, F., Thomsen, M., Mandel, V., Svorenova, T., Ostrozovicova, M., Kulcsarova, K., Berutti, R., Busch, H., Ott, F., Kopajtich, R., Prokisch, H., Kumar, K. R., Mencacci, N. E., Kurian, M. A., Di Fonzo, A., …, & Zech, M. (2023). Dystonia Linked to EIF4A2 Haploinsufficiency: A Disorder of Protein Translation Dysfunction. Movement Disorders. https://doi.org/10.1002/mds.29562
Vancouver
Harrer P, Škorvánek M, Kittke V, Dzinovic I, Borngräber F, Thomsen M, et al. Dystonia Linked to EIF4A2 Haploinsufficiency: A Disorder of Protein Translation Dysfunction. Movement Disorders. 2023. doi:10.1002/mds.29562
BibTeX
@article{Harrer2023,
author = {Harrer, Philip and Škorvánek, Matej and Kittke, Volker and Dzinovic, Ivana and Borngräber, Friederike and Thomsen, Mirja and Mandel, Vanessa and Svorenova, Tatiana and Ostrozovicova, Miriam and Kulcsarova, Kristina and Berutti, Riccardo and Busch, Hauke and Ott, Fabian and Kopajtich, Robert and Prokisch, Holger and Kumar, Kishore R and Mencacci, Niccolo E and Kurian, Manju A and Di Fonzo, Alessio and Boesch, Sylvia and Kühn, Andrea A and Blümlein, Ulrike and Lohmann, Katja and Haslinger, Bernhard and Weise, David and Jech, Robert and Winkelmann, Juliane and Zech, Michael},
title = {Dystonia Linked to EIF4A2 Haploinsufficiency: A Disorder of Protein Translation Dysfunction},
journal = {Movement Disorders},
year = {2023},
doi = {10.1002/mds.29562}
}
EUVIMED